Instant Insights: Lipoprotein (a) (6 min)

Despite advances in understanding the pathogenesis and prevention of atherosclerotic cardiovascular disease, coronary heart disease remains the leading cause of death in the United States. Lipoprotein (a), or Lp(a), is a particularly atherogenic type of lipoprotein, where excess levels significantly influence cardiovascular risk.  

This episode will:

• Review the significant cardiovascular implications of Lp(a) excess
• Describe Lp(a) structure
• Discuss how Lp(a) is measured
• Review the treatment landscape for Lp(a)

To learn more, please review the additional resources below for information on our cardiovascular, metabolic, endocrine, and wellness offerings, as well as educational resources and insights from our team of experts. At Quest Diagnostics, we are committed to providing you with results and insights to support your clinical decisions.

 

Date: 9/10/24

Speaker(s): Maeson Latsko, PhD

Contributor(s): Maeson Latsko, PhD, Trisha Winchester, PhD

 

Additional Resources:

Ordering information: Lipoprotein (a) | Test Detail | Quest Diagnostics

Lipoprotein(a) | Test Summary | Quest Diagnostics

 

Quest Diagnostics Clinical Education Center [Link]

 

 

References:

Wilson DP, Jacobson TA, Jones PH, et al. Use of Lipoprotein(A) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019;13(3):374-392. doi:10.1016/j.jacl.2019.04.010 

 

Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18(3):e308-e319. doi:10.1016/j.jacl.2024.03.001